Healthcare Sector Stocks
The Healthcare sector has a total of 1065 stocks, with a combined market cap of $8.24 trillion, total revenue of $4.52 trillion and a weighted average PE ratio of 39.73.
Market Cap
8.24T
Revenue
4.52T
Profits
207.51B
PE Ratio
39.73
Profit Margin
4.59%
Dividend Yield
0.44%
1065 Stocks
| No. | Symbol | Company Name | Market Cap | % Change | Volume | Revenue |
|---|---|---|---|---|---|---|
| 1 | LLY | Eli Lilly and Company | 833.16B | 0.43% | 2,724,131 | 65.18B |
| 2 | JNJ | Johnson & Johnson | 574.24B | -1.06% | 6,240,241 | 94.19B |
| 3 | ABBV | AbbVie Inc. | 365.02B | -0.15% | 8,800,984 | 61.16B |
| 4 | AZN | AstraZeneca PLC | 307.39B | -1.00% | 2,454,225 | 58.74B |
| 5 | MRK | Merck & Co., Inc. | 294.91B | -1.30% | 11,375,195 | 65.01B |
| 6 | NVS | Novartis AG | 285.81B | -1.06% | 2,023,770 | 56.67B |
| 7 | UNH | UnitedHealth Group Incorporated | 279.32B | 9.37% | 22,098,871 | 447.57B |
| 8 | AMGN | Amgen Inc. | 183.28B | -0.75% | 3,161,690 | 36.75B |
| 9 | TMO | Thermo Fisher Scientific Inc. | 181.84B | 0.27% | 1,287,503 | 44.56B |
| 10 | ABT | Abbott Laboratories | 177.35B | -0.46% | 13,309,631 | 44.33B |
| 11 | GILD | Gilead Sciences, Inc. | 172.28B | -0.95% | 5,430,776 | 29.44B |
| 12 | NVO | Novo Nordisk A/S | 161.63B | 0.65% | 13,913,587 | 48.59B |
| 13 | ISRG | Intuitive Surgical, Inc. | 160.87B | 0.08% | 1,787,364 | 10.06B |
| 14 | PFE | Pfizer Inc. | 154.15B | -2.62% | 46,613,732 | 62.58B |
| 15 | DHR | Danaher Corporation | 135.18B | -0.58% | 2,929,926 | 24.57B |
| 16 | SYK | Stryker Corporation | 127.08B | -0.07% | 1,659,384 | 25.12B |
| 17 | BMY | Bristol-Myers Squibb Company | 117.75B | -2.80% | 9,001,383 | 48.19B |
| 18 | SNY | Sanofi | 112.50B | -1.62% | 2,477,943 | 54.85B |
| 19 | GSK | GSK plc | 111.00B | -0.94% | 3,845,625 | 43.97B |
| 20 | MDT | Medtronic plc | 110.95B | 0.16% | 6,737,686 | 35.48B |
| 21 | VRTX | Vertex Pharmaceuticals Incorporated | 109.85B | -0.56% | 1,028,803 | 12.00B |
| 22 | HCA | HCA Healthcare, Inc. | 109.45B | 1.17% | 1,105,902 | 75.60B |
| 23 | MCK | McKesson Corporation | 104.93B | -0.02% | 892,011 | 397.96B |
| 24 | CVS | CVS Health Corporation | 99.51B | 6.74% | 16,421,532 | 399.83B |
| 25 | BSX | Boston Scientific Corporation | 91.93B | -1.17% | 19,113,058 | 20.07B |
| 26 | REGN | Regeneron Pharmaceuticals, Inc. | 78.02B | -0.36% | 620,748 | 14.34B |
| 27 | CI | The Cigna Group | 72.31B | -0.52% | 1,514,980 | 274.90B |
| 28 | ELV | Elevance Health, Inc. | 68.50B | 3.05% | 2,409,559 | 199.13B |
| 29 | COR | Cencora, Inc. | 62.42B | -0.02% | 1,253,325 | 325.78B |
| 30 | TAK | Takeda Pharmaceutical Company Limited | 57.28B | 0.38% | 4,220,816 | 28.48B |
| 31 | MDLN | Medline Inc. | 56.65B | -1.73% | 5,519,057 | 28.43B |
| 32 | CAH | Cardinal Health, Inc. | 50.07B | 0.07% | 1,449,693 | 244.67B |
| 33 | ZTS | Zoetis Inc. | 49.30B | -1.23% | 3,253,486 | 9.47B |
| 34 | ARGX | argenx SE | 46.67B | 2.30% | 361,784 | 4.24B |
| 35 | EW | Edwards Lifesciences Corporation | 46.61B | -0.43% | 4,013,491 | 6.07B |
| 36 | IDXX | IDEXX Laboratories, Inc. | 45.77B | -0.46% | 619,737 | 4.30B |
| 37 | BDX | Becton, Dickinson and Company | 44.12B | -0.23% | 1,806,860 | 21.92B |
| 38 | HLN | Haleon plc | 43.63B | -0.40% | 6,008,286 | 14.85B |
| 39 | ALNY | Alnylam Pharmaceuticals, Inc. | 42.38B | -3.28% | 1,305,075 | 3.71B |
| 40 | ALC | Alcon Inc. | 36.15B | 0.05% | 1,425,866 | 10.40B |
| 41 | INSM | Insmed Incorporated | 35.19B | -0.48% | 1,350,372 | 606.42M |
| 42 | TEVA | Teva Pharmaceutical Industries Limited | 34.15B | -1.64% | 5,702,374 | 17.26B |
| 43 | ONC | BeOne Medicines AG | 33.69B | 0.44% | 194,566 | 5.34B |
| 44 | RMD | ResMed Inc. | 32.79B | 0.50% | 1,029,983 | 5.40B |
| 45 | A | Agilent Technologies, Inc. | 32.18B | -0.84% | 1,624,611 | 7.07B |
| 46 | GEHC | GE HealthCare Technologies Inc. | 31.82B | -0.95% | 3,201,329 | 20.63B |
| 47 | WAT | Waters Corporation | 30.15B | 1.08% | 757,410 | 3.17B |
| 48 | NTRA | Natera, Inc. | 29.66B | 2.15% | 905,759 | 2.31B |
| 49 | IQV | IQVIA Holdings Inc. | 28.64B | -0.06% | 1,336,049 | 16.31B |
| 50 | VEEV | Veeva Systems Inc. | 28.18B | -1.21% | 1,446,128 | 3.20B |
| 51 | RPRX | Royalty Pharma plc | 27.04B | -0.95% | 2,626,477 | 2.38B |
| 52 | BIIB | Biogen Inc. | 25.77B | 1.90% | 1,515,254 | 9.89B |
| 53 | MTD | Mettler-Toledo International Inc. | 25.72B | 0.27% | 162,060 | 4.03B |
| 54 | PHG | Koninklijke Philips N.V. | 25.46B | -0.70% | 1,261,163 | 20.94B |
| 55 | UTHR | United Therapeutics Corporation | 24.79B | 1.08% | 726,396 | 3.18B |
| 56 | DXCM | DexCom, Inc. | 24.29B | -0.16% | 3,869,399 | 4.66B |
| 57 | HUM | Humana Inc. | 23.67B | 7.94% | 5,411,397 | 129.66B |
| 58 | BNTX | BioNTech SE | 22.66B | -1.82% | 662,139 | 3.37B |
| 59 | LH | Labcorp Holdings Inc. | 22.18B | -1.93% | 465,112 | 13.95B |
| 60 | DGX | Quest Diagnostics Incorporated | 21.78B | -1.08% | 640,726 | 11.04B |
| 61 | STE | STERIS plc | 21.50B | -0.34% | 454,113 | 5.83B |
| 62 | MRNA | Moderna, Inc. | 19.87B | 2.75% | 4,300,898 | 1.94B |
| 63 | ROIV | Roivant Sciences Ltd. | 19.86B | -0.47% | 2,526,534 | 13.31M |
| 64 | ILMN | Illumina, Inc. | 19.33B | -1.02% | 794,134 | 4.34B |
| 65 | RVMD | Revolution Medicines, Inc. | 19.08B | 0.98% | 1,033,721 | - |
| 66 | WST | West Pharmaceutical Services, Inc. | 18.68B | 0.97% | 565,369 | 3.07B |
| 67 | INCY | Incyte Corporation | 18.65B | -1.23% | 1,388,086 | 5.14B |
| 68 | CNC | Centene Corporation | 17.86B | 2.57% | 7,144,026 | 176.15B |
| 69 | ZBH | Zimmer Biomet Holdings, Inc. | 17.69B | 0.44% | 1,744,334 | 8.23B |
| 70 | HOLX | Hologic, Inc. | 16.97B | - | - | 4.13B |
| 71 | THC | Tenet Healthcare Corporation | 16.92B | 2.27% | 1,124,604 | 21.31B |
| 72 | GMAB | Genmab A/S | 16.66B | -0.36% | 1,912,445 | 3.72B |
| 73 | VTRS | Viatris Inc. | 15.32B | -1.86% | 11,618,499 | 14.30B |
| 74 | SMMT | Summit Therapeutics Inc. | 14.90B | 2.84% | 1,503,518 | - |
| 75 | MEDP | Medpace Holdings, Inc. | 14.52B | 2.52% | 329,493 | 2.53B |
| 76 | PODD | Insulet Corporation | 14.02B | -0.51% | 930,269 | 2.71B |
| 77 | BBIO | BridgeBio Pharma, Inc. | 13.94B | -0.48% | 952,041 | 502.08M |
| 78 | RGC | Regencell Bioscience Holdings Limited | 13.78B | -9.63% | 162,559 | - |
| 79 | COO | The Cooper Companies, Inc. | 13.59B | -0.90% | 2,185,747 | 4.15B |
| 80 | ASND | Ascendis Pharma A/S | 13.53B | -2.74% | 486,938 | 845.52M |
| 81 | SNN | Smith & Nephew plc | 13.50B | -2.76% | 1,999,887 | 6.16B |
| 82 | NBIX | Neurocrine Biosciences, Inc. | 13.14B | -1.19% | 1,772,053 | 2.86B |
| 83 | PEN | Penumbra, Inc. | 12.98B | 0.03% | 626,910 | 1.40B |
| 84 | GH | Guardant Health, Inc. | 12.24B | 4.06% | 2,247,214 | 982.02M |
| 85 | FMS | Fresenius Medical Care AG | 12.23B | 1.20% | 411,461 | 23.05B |
| 86 | IONS | Ionis Pharmaceuticals, Inc. | 12.21B | -0.59% | 1,114,196 | 943.71M |
| 87 | GMED | Globus Medical, Inc. | 12.17B | 1.58% | 1,336,758 | 2.94B |
| 88 | ALGN | Align Technology, Inc. | 11.89B | -2.91% | 934,367 | 4.03B |
| 89 | JAZZ | Jazz Pharmaceuticals plc | 11.75B | 2.19% | 800,382 | 4.27B |
| 90 | MDGL | Madrigal Pharmaceuticals, Inc. | 11.74B | -4.12% | 347,701 | 958.40M |
| 91 | ENSG | The Ensign Group, Inc. | 11.71B | 1.22% | 267,425 | 5.06B |
| 92 | EXEL | Exelixis, Inc. | 11.42B | 0.02% | 2,386,210 | 2.32B |
| 93 | ELAN | Elanco Animal Health Incorporated | 11.34B | -0.09% | 3,478,350 | 4.72B |
| 94 | UHS | Universal Health Services, Inc. | 11.03B | -0.40% | 514,218 | 17.36B |
| 95 | SOLV | Solventum Corporation | 10.84B | -1.20% | 1,007,786 | 8.33B |
| 96 | BMRN | BioMarin Pharmaceutical Inc. | 10.81B | 0.02% | 1,256,794 | 3.22B |
| 97 | RDY | Dr. Reddy's Laboratories Limited | 10.72B | -1.45% | 2,282,424 | 3.85B |
| 98 | EHC | Encompass Health Corporation | 10.51B | 0.49% | 1,477,560 | 5.94B |
| 99 | DVA | DaVita Inc. | 10.00B | -0.28% | 652,600 | 13.64B |
| 100 | RVTY | Revvity, Inc. | 9.82B | -0.60% | 735,440 | 2.86B |
| 101 | MASI | Masimo Corporation | 9.33B | 0.13% | 678,792 | 1.53B |
| 102 | ABVX | ABIVAX Société Anonyme | 9.12B | -2.50% | 372,393 | 5.37M |
| 103 | BTSG | BrightSpring Health Services, Inc. | 8.95B | 0.83% | 2,190,926 | 12.91B |
| 104 | PCVX | Vaxcyte, Inc. | 8.73B | 1.45% | 1,064,530 | - |
| 105 | AXSM | Axsome Therapeutics, Inc. | 8.63B | -0.59% | 401,331 | 638.50M |
| 106 | BAX | Baxter International Inc. | 8.58B | -0.18% | 4,740,791 | 11.24B |
| 107 | ARWR | Arrowhead Pharmaceuticals, Inc. | 8.57B | 0.10% | 1,180,490 | 1.09B |
| 108 | PRAX | Praxis Precision Medicines, Inc. | 8.54B | -1.10% | 310,465 | 7.46M |
| 109 | HSIC | Henry Schein, Inc. | 8.47B | -1.35% | 756,332 | 13.18B |
| 110 | TECH | Bio-Techne Corporation | 8.42B | 0.06% | 2,493,980 | 1.22B |
| 111 | TEM | Tempus AI, Inc. | 8.37B | -1.03% | 3,032,578 | 1.27B |
| 112 | CRL | Charles River Laboratories International, Inc. | 8.35B | 0.78% | 686,802 | 4.02B |
| 113 | QGEN | Qiagen N.V. | 8.30B | -1.59% | 1,557,389 | 2.09B |
| 114 | ICLR | ICON Public Limited Company | 8.18B | -2.24% | 534,088 | 8.10B |
| 115 | CYTK | Cytokinetics, Incorporated | 8.06B | 0.83% | 1,327,526 | 88.04M |
| 116 | NUVL | Nuvalent, Inc. | 8.04B | -1.41% | 628,253 | - |
| 117 | ATR | AptarGroup, Inc. | 8.01B | -0.32% | 275,490 | 3.78B |
| 118 | KRYS | Krystal Biotech, Inc. | 7.77B | 0.84% | 244,721 | 389.13M |
| 119 | HALO | Halozyme Therapeutics, Inc. | 7.53B | 0.82% | 972,032 | 1.40B |
| 120 | BIO | Bio-Rad Laboratories, Inc. | 7.50B | -0.30% | 219,249 | 2.58B |
| 121 | MOH | Molina Healthcare, Inc. | 7.37B | -1.28% | 1,550,511 | 43.56B |
| 122 | IBRX | ImmunityBio, Inc. | 7.08B | -3.11% | 12,961,155 | 113.29M |
| 123 | KYMR | Kymera Therapeutics, Inc. | 6.95B | -0.20% | 357,336 | 39.21M |
| 124 | HQY | HealthEquity, Inc. | 6.85B | -2.83% | 1,127,873 | 1.31B |
| 125 | ACLX | Arcellx, Inc. | 6.74B | 0.07% | 915,395 | 22.29M |
| 126 | BLTE | Belite Bio, Inc | 6.68B | -0.81% | 98,416 | - |
| 127 | GKOS | Glaukos Corporation | 6.68B | -1.40% | 707,039 | 507.44M |
| 128 | PTGX | Protagonist Therapeutics, Inc. | 6.62B | 0.84% | 785,095 | 46.02M |
| 129 | RGEN | Repligen Corporation | 6.50B | -1.42% | 654,184 | 738.26M |
| 130 | GRFS | Grifols, S.A. | 6.49B | -1.58% | 562,170 | 8.83B |
| 131 | APGE | Apogee Therapeutics, Inc. | 6.15B | -0.87% | 602,946 | - |
| 132 | CNTA | Centessa Pharmaceuticals plc | 6.12B | -0.30% | 3,258,245 | 15.00M |
| 133 | TERN | Terns Pharmaceuticals, Inc. | 6.07B | -0.30% | 29,578,032 | - |
| 134 | RYTM | Rhythm Pharmaceuticals, Inc. | 5.92B | -0.34% | 747,585 | 189.76M |
| 135 | CGON | CG Oncology, Inc. | 5.89B | 3.35% | 1,707,278 | 4.04M |
| 136 | MIRM | Mirum Pharmaceuticals, Inc. | 5.77B | -0.61% | 724,687 | 521.31M |
| 137 | PTCT | PTC Therapeutics, Inc. | 5.76B | 0.99% | 666,383 | 1.73B |
| 138 | COGT | Cogent Biosciences, Inc. | 5.74B | 0.56% | 2,590,985 | - |
| 139 | SRRK | Scholar Rock Holding Corporation | 5.73B | 2.23% | 1,031,811 | - |
| 140 | BLCO | Bausch + Lomb Corporation | 5.64B | -2.57% | 383,687 | 5.10B |
| 141 | CELC | Celcuity Inc. | 5.59B | 1.17% | 608,715 | - |
| 142 | BRKR | Bruker Corporation | 5.58B | -0.19% | 1,449,036 | 3.44B |
| 143 | XENE | Xenon Pharmaceuticals Inc. | 5.50B | 1.43% | 667,498 | 7.50M |
| 144 | ALKS | Alkermes plc | 5.49B | -3.11% | 2,140,164 | 1.48B |
| 145 | AVTR | Avantor, Inc. | 5.41B | 0.25% | 6,879,066 | 6.55B |
| 146 | CHE | Chemed Corporation | 5.35B | 0.67% | 171,243 | 2.53B |
| 147 | ERAS | Erasca, Inc. | 5.30B | -0.35% | 4,630,927 | - |
| 148 | CAI | Caris Life Sciences, Inc. | 5.30B | -1.37% | 1,508,986 | 812.03M |
| 149 | APLS | Apellis Pharmaceuticals, Inc. | 5.20B | 0.17% | 3,762,161 | 1.00B |
| 150 | TFX | Teleflex Incorporated | 5.11B | 0.41% | 521,390 | 1.99B |
| 151 | PACS | PACS Group, Inc. | 5.10B | -0.31% | 543,870 | 5.29B |
| 152 | LNTH | Lantheus Holdings, Inc. | 5.07B | 2.89% | 603,924 | 1.54B |
| 153 | IMVT | Immunovant, Inc. | 5.01B | -1.12% | 1,350,456 | - |
| 154 | TGTX | TG Therapeutics, Inc. | 4.93B | -0.89% | 1,139,918 | 616.29M |
| 155 | CRSP | CRISPR Therapeutics AG | 4.77B | 1.12% | 1,319,079 | 3.51M |
| 156 | DNTH | Dianthus Therapeutics, Inc. | 4.56B | 0.82% | 349,202 | 2.04M |
| 157 | FOLD | Amicus Therapeutics, Inc. | 4.54B | 0.14% | 1,846,715 | 634.21M |
| 158 | HIMS | Hims & Hers Health, Inc. | 4.44B | -4.08% | 21,484,630 | 2.35B |
| 159 | CORT | Corcept Therapeutics Incorporated | 4.43B | 2.06% | 1,090,930 | 761.41M |
| 160 | ALHC | Alignment Healthcare, Inc. | 4.43B | 16.01% | 14,931,662 | 3.95B |
| 161 | WAY | Waystar Holding Corp. | 4.38B | -3.26% | 1,690,247 | 1.10B |
| 162 | OPCH | Option Care Health, Inc. | 4.34B | 0.04% | 1,180,181 | 5.65B |
| 163 | RDNT | RadNet, Inc. | 4.24B | -0.87% | 659,205 | 2.04B |
| 164 | SHC | Sotera Health Company | 4.16B | -1.55% | 2,534,800 | 1.16B |
| 165 | DOCS | Doximity, Inc. | 4.16B | -2.43% | 1,922,324 | 637.78M |
| 166 | NVST | Envista Holdings Corporation | 4.14B | -2.01% | 3,060,455 | 2.72B |
| 167 | LGND | Ligand Pharmaceuticals Incorporated | 4.09B | 0.73% | 164,459 | 268.09M |
| 168 | BLLN | BillionToOne, Inc. | 4.07B | 3.45% | 397,184 | 305.11M |
| 169 | CRNX | Crinetics Pharmaceuticals, Inc. | 4.02B | 1.88% | 1,642,133 | 7.70M |
| 170 | SYRE | Spyre Therapeutics, Inc. | 4.02B | 4.53% | 799,899 | - |
| 171 | MMSI | Merit Medical Systems, Inc. | 4.01B | -0.60% | 583,029 | 1.52B |
| 172 | AMRX | Amneal Pharmaceuticals, Inc. | 3.93B | -0.24% | 1,534,910 | 3.02B |
| 173 | VKTX | Viking Therapeutics, Inc. | 3.91B | -0.68% | 1,489,520 | - |
| 174 | NAMS | NewAmsterdam Pharma Company N.V. | 3.90B | -0.62% | 1,034,156 | 22.50M |
| 175 | GPCR | Structure Therapeutics Inc. | 3.87B | 5.62% | 908,730 | - |
| 176 | OSCR | Oscar Health, Inc. | 3.86B | 1.65% | 7,393,574 | 11.70B |
| 177 | IRTC | iRhythm Holdings, Inc. | 3.83B | 1.20% | 384,565 | 747.14M |
| 178 | ACAD | ACADIA Pharmaceuticals Inc. | 3.77B | -1.03% | 1,429,377 | 1.07B |
| 179 | KNSA | Kiniksa Pharmaceuticals International, plc | 3.75B | -1.23% | 411,741 | 677.56M |
| 180 | STVN | Stevanato Group S.p.A. | 3.72B | -1.09% | 195,442 | 1.39B |
| 181 | MMED | Minimed Group, Inc. | 3.72B | - | 1,122,868 | 2.89B |
| 182 | TMDX | TransMedics Group, Inc. | 3.68B | 2.40% | 1,296,391 | 605.49M |
| 183 | EWTX | Edgewise Therapeutics, Inc. | 3.49B | -1.01% | 663,979 | - |
| 184 | LIVN | LivaNova PLC | 3.47B | 0.06% | 608,978 | 1.39B |
| 185 | LEGN | Legend Biotech Corporation | 3.33B | -3.69% | 1,373,326 | 1.03B |
| 186 | LQDA | Liquidia Corporation | 3.29B | -0.77% | 937,050 | 158.32M |
| 187 | BKD | Brookdale Senior Living Inc. | 3.27B | -1.01% | 2,730,166 | 3.05B |
| 188 | TLX | Telix Pharmaceuticals Limited | 3.19B | 5.94% | 208,234 | 803.79M |
| 189 | DNLI | Denali Therapeutics Inc. | 3.08B | 0.15% | 1,196,899 | - |
| 190 | TWST | Twist Bioscience Corporation | 3.07B | -2.07% | 1,177,573 | 391.56M |
| 191 | CPRX | Catalyst Pharmaceuticals, Inc. | 3.05B | 0.04% | 1,050,383 | 588.99M |
| 192 | ORKA | Oruka Therapeutics, Inc. | 3.00B | 7.50% | 1,415,754 | - |
| 193 | DYN | Dyne Therapeutics, Inc. | 3.00B | -1.04% | 801,952 | - |
| 194 | ICUI | ICU Medical, Inc. | 2.99B | -2.57% | 236,615 | 2.23B |
| 195 | HNGE | Hinge Health, Inc. | 2.99B | -2.99% | 495,044 | 587.86M |
| 196 | SUPN | Supernus Pharmaceuticals, Inc. | 2.93B | 0.83% | 873,920 | 718.95M |
| 197 | ITGR | Integer Holdings Corporation | 2.93B | -0.61% | 415,841 | 1.85B |
| 198 | TARS | Tarsus Pharmaceuticals, Inc. | 2.93B | -2.04% | 336,224 | 451.36M |
| 199 | TVTX | Travere Therapeutics, Inc. | 2.92B | -0.50% | 876,010 | 490.73M |
| 200 | ARQT | Arcutis Biotherapeutics, Inc. | 2.89B | -1.63% | 774,972 | 376.07M |
| 201 | VERA | Vera Therapeutics, Inc. | 2.85B | -1.10% | 1,165,336 | - |
| 202 | ALMS | Alumis Inc. | 2.84B | 1.69% | 1,126,215 | 24.05M |
| 203 | TNGX | Tango Therapeutics, Inc. | 2.83B | -2.41% | 1,955,625 | 62.38M |
| 204 | PRVA | Privia Health Group, Inc. | 2.81B | 3.66% | 800,435 | 2.12B |
| 205 | TXG | 10x Genomics, Inc. | 2.79B | -0.32% | 1,640,236 | 642.82M |
| 206 | HAE | Haemonetics Corporation | 2.77B | 1.88% | 773,240 | 1.32B |
| 207 | RCUS | Arcus Biosciences, Inc. | 2.77B | -0.76% | 714,514 | 247.00M |
| 208 | CON | Concentra Group Holdings Parent, Inc. | 2.74B | 1.62% | 736,789 | 2.16B |
| 209 | IDYA | IDEAYA Biosciences, Inc. | 2.71B | -4.42% | 1,439,006 | 218.71M |
| 210 | SLNO | Soleno Therapeutics, Inc. | 2.71B | 0.19% | 17,670,064 | 190.41M |
| 211 | PBH | Prestige Consumer Healthcare Inc. | 2.63B | 0.89% | 703,884 | 1.10B |
| 212 | WRBY | Warby Parker Inc. | 2.59B | 0.67% | 1,517,564 | 871.91M |
| 213 | NHC | National HealthCare Corporation | 2.59B | 1.40% | 132,151 | 1.52B |
| 214 | ELVN | Enliven Therapeutics, Inc. | 2.58B | 10.84% | 3,055,442 | - |
| 215 | KOD | Kodiak Sciences Inc. | 2.58B | 7.15% | 1,554,820 | - |
| 216 | VCYT | Veracyte, Inc. | 2.55B | -0.53% | 504,841 | 517.15M |
| 217 | IRON | Disc Medicine, Inc. | 2.55B | 1.56% | 413,561 | - |
| 218 | HCM | HUTCHMED (China) Limited | 2.53B | -0.39% | 20,379 | 548.51M |
| 219 | LMAT | LeMaitre Vascular, Inc. | 2.51B | 1.07% | 154,102 | 249.60M |
| 220 | LFST | LifeStance Health Group, Inc. | 2.50B | 0.16% | 1,965,450 | 1.42B |
| 221 | GRDN | Guardian Pharmacy Services, Inc. | 2.49B | 2.13% | 542,669 | 1.45B |
| 222 | CLDX | Celldex Therapeutics, Inc. | 2.46B | -0.06% | 633,166 | 1.55M |
| 223 | AAPG | Ascentage Pharma Group International | 2.44B | -0.29% | 2,540 | 82.08M |
| 224 | IMNM | Immunome, Inc. | 2.44B | 0.47% | 732,865 | 6.94M |
| 225 | BEAM | Beam Therapeutics Inc. | 2.43B | 1.07% | 1,896,105 | 139.74M |
| 226 | SRPT | Sarepta Therapeutics, Inc. | 2.42B | 1.23% | 1,882,505 | 2.20B |
| 227 | RLAY | Relay Therapeutics, Inc. | 2.41B | 8.27% | 5,421,640 | 15.36M |
| 228 | BCRX | BioCryst Pharmaceuticals, Inc. | 2.41B | 1.27% | 2,243,593 | 874.84M |
| 229 | ZLAB | Zai Lab Limited | 2.37B | 2.44% | 472,461 | 460.16M |
| 230 | ACHC | Acadia Healthcare Company, Inc. | 2.34B | 1.93% | 1,758,828 | 3.31B |
| 231 | MLYS | Mineralys Therapeutics, Inc. | 2.33B | 0.28% | 2,060,525 | - |
| 232 | HTFL | HeartFlow, Inc. | 2.30B | 3.51% | 1,138,546 | 176.03M |
| 233 | XRAY | DENTSPLY SIRONA Inc. | 2.30B | -1.03% | 2,918,435 | 3.68B |
| 234 | RARE | Ultragenyx Pharmaceutical Inc. | 2.27B | 1.22% | 1,477,844 | 673.00M |
| 235 | PAHC | Phibro Animal Health Corporation | 2.26B | 1.31% | 233,966 | 1.46B |
| 236 | DAWN | Day One Biopharmaceuticals, Inc. | 2.22B | - | 1,825,012 | 158.18M |
| 237 | ADMA | ADMA Biologics, Inc. | 2.21B | -0.22% | 2,775,078 | 510.17M |
| 238 | NKTR | Nektar Therapeutics | 2.19B | 2.03% | 483,934 | 55.23M |
| 239 | SNDX | Syndax Pharmaceuticals, Inc. | 2.17B | 1.44% | 825,745 | 172.35M |
| 240 | NEOG | Neogen Corporation | 2.17B | 4.39% | 3,217,319 | 880.32M |
| 241 | MANE | Veradermics, Incorporated | 2.12B | -11.14% | 332,351 | - |
| 242 | ADPT | Adaptive Biotechnologies Corporation | 2.11B | -2.63% | 1,405,270 | 276.98M |
| 243 | AUPH | Aurinia Pharmaceuticals Inc. | 2.10B | -1.31% | 1,061,304 | 283.06M |
| 244 | AGIO | Agios Pharmaceuticals, Inc. | 2.06B | 0.89% | 1,483,592 | 54.03M |
| 245 | DFTX | Definium Therapeutics, Inc. | 2.05B | 0.73% | 1,351,717 | - |
| 246 | TYRA | Tyra Biosciences, Inc. | 2.03B | -3.08% | 841,701 | - |
| 247 | SEM | Select Medical Holdings Corporation | 2.03B | -0.18% | 1,014,896 | 5.45B |
| 248 | GRAL | GRAIL, Inc. | 2.02B | -5.01% | 1,092,482 | 147.17M |
| 249 | STOK | Stoke Therapeutics, Inc. | 2.00B | 3.02% | 461,037 | 184.42M |
| 250 | WGS | GeneDx Holdings Corp. | 1.96B | 0.42% | 1,080,869 | 427.54M |
| 251 | AHG | Akso Health Group | 1.95B | 1.33% | 191,545 | 14.84M |
| 252 | BHC | Bausch Health Companies Inc. | 1.95B | -2.77% | 1,075,234 | 10.27B |
| 253 | ZYME | Zymeworks Inc. | 1.92B | 0.62% | 455,357 | 105.97M |
| 254 | GLPG | Galapagos NV | 1.88B | -1.60% | 248,800 | 1.31B |
| 255 | CAPR | Capricor Therapeutics, Inc. | 1.84B | 0.92% | 713,722 | 11.13M |
| 256 | PHVS | Pharvaris N.V. | 1.82B | -2.01% | 149,199 | - |
| 257 | OCUL | Ocular Therapeutix, Inc. | 1.82B | 3.35% | 3,885,535 | 51.95M |
| 258 | AMLX | Amylyx Pharmaceuticals, Inc. | 1.80B | 2.84% | 1,229,535 | -665.00K |
| 259 | ANAB | AnaptysBio, Inc. | 1.79B | -0.48% | 295,313 | 234.60M |
| 260 | MESO | Mesoblast Limited | 1.78B | -7.97% | 447,958 | 65.38M |
| 261 | MD | Pediatrix Medical Group, Inc. | 1.76B | 0.23% | 676,665 | 1.91B |
| 262 | ESTA | Establishment Labs Holdings Inc. | 1.73B | -2.19% | 316,581 | 211.08M |
| 263 | INVA | Innoviva, Inc. | 1.72B | 1.13% | 530,352 | 411.33M |
| 264 | PVLA | Palvella Therapeutics, Inc. | 1.72B | 0.14% | 187,664 | - |
| 265 | AORT | Artivion, Inc. | 1.71B | 5.29% | 1,009,317 | 441.33M |
| 266 | VCEL | Vericel Corporation | 1.70B | -2.20% | 499,042 | 276.26M |
| 267 | NRIX | Nurix Therapeutics, Inc. | 1.69B | 3.55% | 1,741,688 | 83.98M |
| 268 | ADUS | Addus HomeCare Corporation | 1.69B | -0.37% | 208,150 | 1.42B |
| 269 | RXRX | Recursion Pharmaceuticals, Inc. | 1.68B | 1.27% | 10,451,796 | 74.68M |
| 270 | TRVI | Trevi Therapeutics, Inc. | 1.68B | 2.26% | 1,446,237 | - |
| 271 | ATEC | Alphatec Holdings, Inc. | 1.67B | 0.55% | 1,705,451 | 764.16M |
| 272 | ANIP | ANI Pharmaceuticals, Inc. | 1.66B | 2.94% | 398,912 | 883.37M |
| 273 | SION | Sionna Therapeutics, Inc. | 1.65B | -1.66% | 373,547 | - |
| 274 | AHCO | AdaptHealth Corp. | 1.62B | -1.08% | 929,041 | 3.24B |
| 275 | SGRY | Surgery Partners, Inc. | 1.62B | 2.76% | 893,837 | 3.31B |
| 276 | IMCR | Immunocore Holdings plc | 1.62B | 0.06% | 727,280 | 400.02M |
| 277 | AXGN | Axogen, Inc. | 1.61B | -5.06% | 810,542 | 225.21M |
| 278 | RAPP | Rapport Therapeutics, Inc. | 1.60B | 3.43% | 349,853 | - |
| 279 | NTLA | Intellia Therapeutics, Inc. | 1.60B | 1.88% | 2,343,024 | 67.67M |
| 280 | HRMY | Harmony Biosciences Holdings, Inc. | 1.60B | -0.32% | 537,498 | 868.45M |
| 281 | OGN | Organon & Co. | 1.59B | 1.16% | 3,020,705 | 6.22B |
| 282 | OMCL | Omnicell, Inc. | 1.57B | 1.14% | 326,870 | 1.18B |
| 283 | INSP | Inspire Medical Systems, Inc. | 1.57B | 0.52% | 1,083,551 | 911.98M |
| 284 | OCS | Oculis Holding AG | 1.56B | 0.23% | 173,627 | 1.51M |
| 285 | NUVB | Nuvation Bio Inc. | 1.55B | 1.35% | 2,842,794 | 62.90M |
| 286 | GENB | Generate Biomedicines, Inc. | 1.51B | -2.23% | 236,439 | 31.89M |
| 287 | SNDA | Sonida Senior Living, Inc. | 1.50B | -1.39% | 399,016 | 336.39M |
| 288 | DMRA | Damora Therapeutics, Inc. | 1.47B | -0.69% | 201,247 | - |
| 289 | VIR | Vir Biotechnology, Inc. | 1.47B | 1.21% | 1,413,313 | 68.56M |
| 290 | SVRA | Savara Inc. | 1.46B | 3.21% | 1,287,869 | - |
| 291 | ATRC | AtriCure, Inc. | 1.46B | -1.03% | 399,534 | 534.53M |
| 292 | ARDX | Ardelyx, Inc. | 1.46B | -0.34% | 1,803,545 | 407.32M |
| 293 | PGEN | Precigen, Inc. | 1.46B | -1.67% | 2,432,727 | 9.68M |
| 294 | UFPT | UFP Technologies, Inc. | 1.46B | -1.72% | 176,688 | 602.80M |
| 295 | PRGO | Perrigo Company plc | 1.45B | -0.28% | 6,965,783 | 4.25B |
| 296 | NBTX | Nanobiotix S.A. | 1.44B | -8.00% | 53,763 | 38.27M |
| 297 | MBX | MBX Biosciences, Inc. | 1.43B | -3.55% | 1,225,204 | - |
| 298 | VRDN | Viridian Therapeutics, Inc. | 1.43B | 0.43% | 6,601,659 | 70.85M |
| 299 | MAZE | Maze Therapeutics, Inc. | 1.41B | -2.31% | 501,364 | 2.50M |
| 300 | AVAH | Aveanna Healthcare Holdings Inc. | 1.40B | -0.62% | 922,902 | 2.43B |
| 301 | BCAX | Bicara Therapeutics Inc. | 1.39B | 2.11% | 798,087 | - |
| 302 | BHVN | Biohaven Ltd. | 1.39B | 1.20% | 1,345,460 | - |
| 303 | ATAI | AtaiBeckley Inc. | 1.38B | -1.56% | 2,555,815 | 4.09M |
| 304 | IMTX | Immatics N.V. | 1.37B | -0.58% | 294,335 | 56.67M |
| 305 | ASTH | Astrana Health, Inc. | 1.37B | 6.73% | 641,895 | 3.18B |
| 306 | GLUE | Monte Rosa Therapeutics, Inc. | 1.37B | 1.12% | 343,706 | 123.67M |
| 307 | IOVA | Iovance Biotherapeutics, Inc. | 1.37B | 0.61% | 9,693,015 | 263.50M |
| 308 | PLSE | Pulse Biosciences, Inc. | 1.36B | -12.99% | 508,897 | 350.00K |
| 309 | PGNY | Progyny, Inc. | 1.34B | 2.26% | 1,466,745 | 1.29B |
| 310 | ZBIO | Zenas BioPharma, Inc. | 1.34B | 0.99% | 456,513 | 10.00M |
| 311 | WVE | Wave Life Sciences Ltd. | 1.34B | 0.14% | 2,707,214 | 42.73M |
| 312 | OLMA | Olema Pharmaceuticals, Inc. | 1.33B | 0.53% | 636,247 | - |
| 313 | HCSG | Healthcare Services Group, Inc. | 1.32B | 0.16% | 622,693 | 1.84B |
| 314 | HROW | Harrow, Inc. | 1.32B | 0.85% | 358,820 | 272.30M |
| 315 | TSHA | Taysha Gene Therapies, Inc. | 1.31B | -1.72% | 1,406,410 | 9.77M |
| 316 | PRCT | PROCEPT BioRobotics Corporation | 1.31B | -2.48% | 1,626,734 | 308.05M |
| 317 | NVAX | Novavax, Inc. | 1.30B | 0.13% | 2,373,171 | 1.12B |
| 318 | ENOV | Enovis Corporation | 1.29B | -1.05% | 559,286 | 2.25B |
| 319 | ARDT | Ardent Health, Inc. | 1.29B | 0.78% | 231,858 | 6.32B |
| 320 | TNDM | Tandem Diabetes Care, Inc. | 1.25B | -4.64% | 1,528,521 | 1.01B |
| 321 | MLTX | MoonLake Immunotherapeutics | 1.23B | 0.59% | 972,932 | - |
| 322 | CRVS | Corvus Pharmaceuticals, Inc. | 1.21B | -2.45% | 684,520 | - |
| 323 | NNNN | Anbio Biotechnology | 1.20B | 4.69% | 25,151 | 6.92M |
| 324 | IRMD | IRADIMED CORPORATION | 1.20B | -2.27% | 112,149 | 83.81M |
| 325 | NVCR | NovoCure Limited | 1.18B | -1.90% | 745,538 | 655.35M |
| 326 | PHAR | Pharming Group N.V. | 1.15B | -0.48% | 11,454 | 376.13M |
| 327 | KMTS | Kestra Medical Technologies, Ltd. | 1.14B | 0.88% | 245,060 | 83.72M |
| 328 | DBVT | DBV Technologies S.A. | 1.14B | 1.92% | 191,176 | 5.64M |
| 329 | EYPT | EyePoint, Inc. | 1.13B | 3.51% | 825,706 | 31.37M |
| 330 | USPH | U.S. Physical Therapy, Inc. | 1.13B | 1.11% | 133,407 | 773.34M |
| 331 | SEPN | Septerna, Inc. | 1.12B | 0.24% | 189,550 | 45.95M |
| 332 | GERN | Geron Corporation | 1.11B | -0.57% | 17,088,277 | 183.88M |
| 333 | AVBP | ArriVent BioPharma, Inc. | 1.11B | 0.88% | 239,631 | - |
| 334 | QURE | uniQure N.V. | 1.07B | -1.44% | 1,092,228 | 16.10M |
| 335 | INNV | InnovAge Holding Corp. | 1.07B | -1.00% | 275,331 | 915.37M |
| 336 | PNTG | The Pennant Group, Inc. | 1.07B | 2.11% | 327,155 | 947.71M |
| 337 | CNMD | CONMED Corporation | 1.06B | 1.35% | 441,318 | 1.37B |
| 338 | MPLT | MapLight Therapeutics, Inc. | 1.06B | 6.77% | 341,043 | - |
| 339 | ALVO | Alvotech | 1.06B | -10.55% | 649,919 | 588.90M |
| 340 | NEO | NeoGenomics, Inc. | 1.05B | 0.50% | 1,643,065 | 727.33M |
| 341 | STAA | STAAR Surgical Company | 1.04B | 0.62% | 903,402 | 239.44M |
| 342 | COLL | Collegium Pharmaceutical, Inc. | 1.04B | 0.52% | 366,799 | 780.57M |
| 343 | BFLY | Butterfly Network, Inc. | 1.03B | -1.94% | 2,965,201 | 97.61M |
| 344 | KALV | KalVista Pharmaceuticals, Inc. | 1.03B | -0.35% | 1,158,980 | 73.62M |
| 345 | QDEL | QuidelOrtho Corporation | 1.02B | -5.67% | 1,784,841 | 2.73B |
| 346 | XERS | Xeris Biopharma Holdings, Inc. | 1.01B | -2.98% | 1,661,587 | 291.85M |
| 347 | IVA | Inventiva S.A. | 1.01B | -5.82% | 260,745 | 9.31M |
| 348 | ABCL | AbCellera Biologics Inc. | 1.00B | -2.65% | 3,959,241 | 75.13M |
| 349 | AZTA | Azenta, Inc. | 1,000.00M | -3.90% | 955,736 | 595.03M |
| 350 | CLOV | Clover Health Investments, Corp. | 996.87M | 1.60% | 7,510,073 | 1.92B |
| 351 | ANNX | Annexon, Inc. | 961.24M | 3.28% | 2,247,278 | - |
| 352 | CMPX | Compass Therapeutics, Inc. | 956.27M | -3.28% | 1,624,354 | 850.00K |
| 353 | SSII | SS Innovations International, Inc. | 955.71M | -0.62% | 31,055 | 42.48M |
| 354 | CRON | Cronos Group Inc. | 953.33M | -2.33% | 675,558 | 146.59M |
| 355 | TDOC | Teladoc Health, Inc. | 949.07M | - | 2,877,622 | 2.53B |
| 356 | AMPH | Amphastar Pharmaceuticals, Inc. | 933.72M | - | 351,443 | 719.89M |
| 357 | CTMX | CytomX Therapeutics, Inc. | 929.56M | -2.27% | 3,189,368 | 76.20M |
| 358 | AKTS | Aktis Oncology, Inc. | 924.21M | 2.14% | 349,095 | 6.50M |
| 359 | BLFS | BioLife Solutions, Inc. | 923.98M | -0.73% | 484,367 | 96.21M |
| 360 | EVO | Evotec SE | 917.19M | -1.53% | 321,979 | 887.40M |
| 361 | VOR | Vor Biopharma Inc. | 913.03M | 3.56% | 2,284,780 | - |
| 362 | PCRX | Pacira BioSciences, Inc. | 912.24M | 1.17% | 462,810 | 726.41M |
| 363 | INBX | Inhibrx Biosciences, Inc. | 910.75M | -2.15% | 142,161 | 1.30M |
| 364 | GHRS | GH Research PLC | 910.59M | -3.04% | 70,137 | - |
| 365 | PHAT | Phathom Pharmaceuticals, Inc. | 910.12M | 2.67% | 838,745 | 175.11M |
| 366 | JANX | Janux Therapeutics, Inc. | 908.22M | -0.07% | 570,257 | 10.00M |
| 367 | CDNA | CareDx, Inc. | 904.99M | -0.84% | 483,983 | 379.81M |
| 368 | XNCR | Xencor, Inc. | 902.80M | -1.05% | 489,902 | 125.58M |
| 369 | CGEM | Cullinan Therapeutics, Inc. | 899.42M | -0.40% | 462,326 | - |
| 370 | EVMN | Evommune, Inc. | 892.90M | 0.85% | 453,171 | 13.00M |
| 371 | ORIC | ORIC Pharmaceuticals, Inc. | 890.18M | -0.45% | 1,443,354 | - |
| 372 | FTRE | Fortrea Holdings Inc. | 889.19M | 5.55% | 1,026,363 | 2.72B |
| 373 | OPK | OPKO Health, Inc. | 888.11M | -0.85% | 1,679,630 | 606.88M |
| 374 | URGN | UroGen Pharma Ltd. | 877.74M | -3.12% | 506,920 | 109.79M |
| 375 | ABUS | Arbutus Biopharma Corporation | 871.83M | - | 841,131 | 14.08M |
| 376 | LMRI | Lumexa Imaging Holdings, Inc. | 866.91M | 0.89% | 655,939 | 1.02B |
| 377 | INMD | InMode Ltd. | 864.85M | -0.44% | 894,650 | 370.50M |
| 378 | TALK | Talkspace, Inc. | 862.11M | -0.77% | 4,357,463 | 228.87M |
| 379 | CERT | Certara, Inc. | 861.69M | 2.93% | 3,069,677 | 418.84M |
| 380 | TBPH | Theravance Biopharma, Inc. | 852.72M | 2.86% | 422,641 | 107.46M |
| 381 | SDGR | Schrödinger, Inc. | 840.87M | -1.13% | 845,463 | 255.87M |
| 382 | SANA | Sana Biotechnology, Inc. | 840.63M | -2.17% | 1,927,135 | - |
| 383 | SLS | SELLAS Life Sciences Group, Inc. | 809.92M | -0.44% | 3,213,383 | - |
| 384 | SPRY | ARS Pharmaceuticals, Inc. | 809.27M | -2.86% | 1,020,319 | 84.28M |
| 385 | JBIO | Jade Biosciences, Inc. | 806.81M | 1.18% | 601,789 | - |
| 386 | MNKD | MannKind Corporation | 791.82M | 0.39% | 3,022,264 | 348.97M |
| 387 | OMER | Omeros Corporation | 790.52M | 0.87% | 1,237,499 | - |
| 388 | BIOA | BioAge Labs, Inc. | 781.53M | 0.46% | 276,246 | 9.00M |
| 389 | KURA | Kura Oncology, Inc. | 779.07M | 3.89% | 1,270,560 | 67.48M |
| 390 | MGTX | MeiraGTx Holdings plc | 774.55M | -0.11% | 635,708 | 81.39M |
| 391 | SLDB | Solid Biosciences Inc. | 761.55M | - | 835,740 | - |
| 392 | DSGN | Design Therapeutics, Inc. | 753.64M | -2.47% | 364,644 | - |
| 393 | TLRY | Tilray Brands, Inc. | 750.83M | -3.00% | 2,318,168 | 858.28M |
| 394 | DRUG | Bright Minds Biosciences Inc. | 750.27M | 2.52% | 163,762 | - |
| 395 | MRVI | Maravai LifeSciences Holdings, Inc. | 742.92M | -2.03% | 1,943,326 | 185.74M |
| 396 | CSTL | Castle Biosciences, Inc. | 738.23M | 0.40% | 281,168 | 344.23M |
| 397 | BVS | Bioventus Inc. | 735.09M | -2.00% | 644,476 | 568.09M |
| 398 | TENX | Tenax Therapeutics, Inc. | 733.88M | -1.95% | 289,846 | - |
| 399 | OMDA | Omada Health, Inc. | 730.68M | -1.43% | 509,754 | 260.21M |
| 400 | ARVN | Arvinas, Inc. | 727.24M | 1.34% | 917,641 | 262.60M |
| 401 | IART | Integra LifeSciences Holdings Corporation | 727.15M | 0.21% | 825,373 | 1.64B |
| 402 | AMN | AMN Healthcare Services, Inc. | 720.17M | 0.38% | 951,432 | 2.73B |
| 403 | NUTX | Nutex Health Inc. | 717.04M | 2.24% | 180,417 | 875.26M |
| 404 | CMPS | COMPASS Pathways plc | 714.24M | -3.65% | 1,381,413 | - |
| 405 | EHAB | Enhabit, Inc. | 709.62M | 0.14% | 1,090,538 | 1.06B |
| 406 | RLMD | Relmada Therapeutics, Inc. | 708.00M | -2.17% | 755,190 | - |
| 407 | SGP | SpyGlass Pharma, Inc. | 704.30M | -6.98% | 90,274 | - |
| 408 | GDRX | GoodRx Holdings, Inc. | 702.28M | -0.97% | 861,720 | 796.85M |
| 409 | ETON | Eton Pharmaceuticals, Inc. | 683.75M | 0.24% | 331,338 | 79.95M |
| 410 | ANRO | Alto Neuroscience, Inc. | 682.04M | -5.24% | 266,662 | - |
| 411 | LXRX | Lexicon Pharmaceuticals, Inc. | 677.89M | 0.63% | 1,888,215 | 49.80M |
| 412 | CBLL | CeriBell, Inc. | 672.65M | -1.60% | 247,403 | 89.06M |
| 413 | BBOT | BridgeBio Oncology Therapeutics, Inc. | 672.28M | -5.72% | 380,115 | - |
| 414 | GYRE | Gyre Therapeutics, Inc. | 650.16M | - | 79,773 | 116.59M |
| 415 | PSNL | Personalis, Inc. | 645.86M | -6.23% | 1,703,236 | 69.65M |
| 416 | REPL | Replimune Group, Inc. | 644.07M | -8.67% | 3,402,666 | - |
| 417 | LBRX | LB Pharmaceuticals Inc | 640.07M | -6.09% | 186,868 | - |
| 418 | ALLO | Allogene Therapeutics, Inc. | 638.70M | 0.77% | 3,897,843 | 22.00K |
| 419 | CBIO | Crescent Biopharma, Inc. | 638.04M | -0.88% | 264,950 | 10.84M |
| 420 | AVNS | Avanos Medical, Inc. | 636.69M | -1.01% | 349,826 | 701.20M |
| 421 | DRTS | Alpha Tau Medical Ltd. | 628.39M | 4.54% | 229,350 | - |
| 422 | PRME | Prime Medicine, Inc. | 603.84M | 2.10% | 1,346,881 | 4.63M |
| 423 | HSTM | HealthStream, Inc. | 603.27M | 0.74% | 204,161 | 304.06M |
| 424 | ESPR | Esperion Therapeutics, Inc. | 593.23M | -9.41% | 8,963,476 | 403.14M |
| 425 | CTKB | Cytek Biosciences, Inc. | 591.33M | 1.77% | 501,320 | 201.49M |
| 426 | OCGN | Ocugen, Inc. | 587.94M | -1.69% | 4,926,299 | 4.41M |
| 427 | SIBN | SI-BONE, Inc. | 581.66M | -0.30% | 963,923 | 200.93M |
| 428 | MDXG | MiMedx Group, Inc. | 573.47M | -0.52% | 811,847 | 418.63M |
| 429 | ZVRA | Zevra Therapeutics, Inc. | 568.33M | -0.62% | 708,120 | 106.47M |
| 430 | CRMD | CorMedix Inc. | 566.79M | 1.27% | 896,943 | 311.71M |
| 431 | IRWD | Ironwood Pharmaceuticals, Inc. | 564.18M | -1.98% | 1,078,172 | 296.15M |
| 432 | KYTX | Kyverna Therapeutics, Inc. | 564.05M | 3.90% | 645,351 | - |
| 433 | PRTA | Prothena Corporation plc | 557.71M | 3.19% | 481,342 | 9.68M |
| 434 | PROK | ProKidney Corp. | 552.51M | 1.10% | 951,561 | 893.00K |
| 435 | PHR | Phreesia, Inc. | 550.51M | -0.98% | 2,686,934 | 480.59M |
| 436 | TCMD | Tactile Systems Technology, Inc. | 547.15M | -2.12% | 262,992 | 329.52M |
| 437 | TECX | Tectonic Therapeutic, Inc. | 545.27M | -3.14% | 311,547 | - |
| 438 | BWAY | BrainsWay Ltd. | 544.09M | -2.54% | 181,556 | 52.23M |
| 439 | ZURA | Zura Bio Limited | 536.08M | -6.77% | 397,951 | - |
| 440 | RIGL | Rigel Pharmaceuticals, Inc. | 530.73M | 5.01% | 388,886 | 294.28M |
| 441 | UPB | Upstream Bio, Inc. | 527.87M | -0.21% | 316,822 | 2.85M |
| 442 | LRMR | Larimar Therapeutics, Inc. | 523.57M | -0.20% | 1,087,690 | - |
| 443 | EMBC | Embecta Corp. | 522.91M | -1.12% | 511,160 | 1.08B |
| 444 | FDMT | 4D Molecular Therapeutics, Inc. | 522.77M | 3.02% | 1,051,240 | 85.21M |
| 445 | FULC | Fulcrum Therapeutics, Inc. | 521.48M | - | 905,867 | 80.00M |
| 446 | ACRS | Aclaris Therapeutics, Inc. | 521.23M | -1.32% | 1,094,927 | 7.83M |
| 447 | VALN | Valneva SE | 517.72M | -0.17% | 53,457 | 205.07M |
| 448 | AGMB | AgomAb Therapeutics NV | 512.22M | -10.17% | 185,839 | - |
| 449 | AVR | Anteris Technologies Global Corp. | 509.23M | 3.10% | 635,051 | 1.91M |
| 450 | LYEL | Lyell Immunopharma, Inc. | 508.09M | 0.41% | 102,028 | 36.00K |
| 451 | MCTA | Charming Medical Limited | 504.26M | -0.83% | - | 5.42M |
| 452 | AQST | Aquestive Therapeutics, Inc. | 504.05M | 0.98% | 1,156,816 | 44.55M |
| 453 | TRDA | Entrada Therapeutics, Inc. | 498.60M | -0.22% | 155,630 | 25.42M |
| 454 | CATX | Perspective Therapeutics, Inc. | 497.89M | -0.23% | 514,590 | 884.00K |
| 455 | FBRX | Forte Biosciences, Inc. | 491.17M | -1.02% | 188,119 | - |
| 456 | ENGN | enGene Holdings Inc. | 491.03M | 1.24% | 357,784 | - |
| 457 | NPCE | NeuroPace, Inc. | 488.51M | -0.62% | 118,837 | 99.99M |
| 458 | STTK | Shattuck Labs, Inc. | 485.21M | - | 433,346 | 1.00M |
| 459 | IMMX | Immix Biopharma, Inc. | 481.45M | 5.82% | 856,196 | - |
| 460 | VSTM | Verastem, Inc. | 478.70M | -0.55% | 1,152,770 | 30.91M |
| 461 | KMDA | Kamada Ltd. | 476.75M | -0.36% | 19,764 | 180.46M |
| 462 | AVIR | Atea Pharmaceuticals, Inc. | 475.64M | 1.70% | 322,636 | - |
| 463 | EIKN | Eikon Therapeutics, Inc. | 475.34M | -6.99% | 335,353 | - |
| 464 | CTNM | Contineum Therapeutics, Inc. | 475.29M | -5.28% | 213,826 | - |
| 465 | VTVT | vTv Therapeutics Inc. | 474.66M | -3.26% | 92,295 | 17.00K |
| 466 | ADCT | ADC Therapeutics SA | 472.61M | 1.36% | 800,565 | 81.36M |
| 467 | OFIX | Orthofix Medical Inc. | 470.09M | -0.51% | 252,282 | 822.31M |
| 468 | LXEO | Lexeo Therapeutics, Inc. | 467.49M | 9.36% | 1,145,257 | - |
| 469 | YDES | YD Bio Limited | 462.00M | -7.76% | 11,331 | 510.36K |
| 470 | FLGT | Fulgent Genetics, Inc. | 458.92M | -3.11% | 582,317 | 322.67M |
| 471 | RGNX | REGENXBIO Inc. | 454.23M | - | 494,244 | 170.44M |
| 472 | ASMB | Assembly Biosciences, Inc. | 452.56M | -2.36% | 67,431 | 72.30M |
| 473 | ABSI | Absci Corporation | 446.82M | -1.35% | 3,822,190 | 2.80M |
| 474 | VREX | Varex Imaging Corporation | 443.93M | 0.28% | 202,466 | 854.40M |
| 475 | MYGN | Myriad Genetics, Inc. | 443.23M | 1.50% | 1,178,015 | 824.50M |
| 476 | VNDA | Vanda Pharmaceuticals Inc. | 440.35M | 6.89% | 1,414,428 | 216.11M |
| 477 | ALT | Altimmune, Inc. | 439.76M | 1.50% | 2,039,568 | 41.00K |
| 478 | ARMP | Armata Pharmaceuticals, Inc. | 437.76M | 13.27% | 120,556 | 4.90M |
| 479 | EPRX | Eupraxia Pharmaceuticals Inc. | 437.01M | -4.65% | 140,697 | - |
| 480 | PACB | Pacific Biosciences of California, Inc. | 434.88M | 1.41% | 4,274,766 | 160.01M |
| 481 | BBNX | Beta Bionics, Inc. | 431.84M | -2.21% | 632,149 | 100.25M |
| 482 | AUNA | Auna S.A. | 430.02M | -0.51% | 95,205 | 1.30B |
| 483 | STRO | Sutro Biopharma, Inc. | 425.94M | 7.35% | 410,491 | 102.48M |
| 484 | AURA | Aura Biosciences, Inc. | 425.32M | -0.75% | 442,324 | - |
| 485 | XOMA | XOMA Royalty Corporation | 412.05M | 2.46% | 213,287 | 52.15M |
| 486 | IPSC | Century Therapeutics, Inc. | 406.17M | 3.20% | 1,574,233 | 109.16M |
| 487 | CYH | Community Health Systems, Inc. | 405.61M | 2.02% | 1,363,864 | 12.49B |
| 488 | EBS | Emergent BioSolutions Inc. | 405.41M | -3.09% | 668,201 | 742.90M |
| 489 | ANGO | AngioDynamics, Inc. | 404.32M | -1.42% | 682,760 | 313.73M |
| 490 | WEAV | Weave Communications, Inc. | 401.89M | 0.59% | 1,144,022 | 239.02M |
| 491 | KIDS | OrthoPediatrics Corp. | 398.39M | -1.13% | 92,275 | 236.35M |
| 492 | DNA | Ginkgo Bioworks Holdings, Inc. | 396.97M | -0.73% | 852,779 | 170.16M |
| 493 | NAUT | Nautilus Biotechnology, Inc. | 394.88M | -6.87% | 392,442 | - |
| 494 | ENTA | Enanta Pharmaceuticals, Inc. | 389.73M | 1.36% | 91,752 | 66.98M |
| 495 | NMRA | Neumora Therapeutics, Inc. | 387.75M | 0.47% | 1,301,846 | - |
| 496 | NRC | National Research Corporation | 387.60M | -1.67% | 56,056 | 137.39M |
| 497 | LCTX | Lineage Cell Therapeutics, Inc. | 378.61M | -1.30% | 1,039,458 | 14.56M |
| 498 | RCKT | Rocket Pharmaceuticals, Inc. | 377.82M | 0.58% | 2,275,173 | - |
| 499 | CGC | Canopy Growth Corporation | 374.90M | -2.74% | 3,556,874 | 203.04M |
| 500 | BNTC | Benitec Biopharma Inc. | 373.72M | -0.73% | 83,750 | - |